Тако ми рекла докторка која ми ординира ову главну терапију - ваљда због те терапије и чињенице да сам прележао ковид...

tenksic

sent from novi mnogo jak bubamoto.

26 minutes ago, Hamlet Strašni said:

Тако ми рекла докторка која ми ординира ову главну терапију - ваљда због те терапије и чињенице да сам прележао ковид...

Ja bih tu konsultuvao i drugo mišljenje. Upravo je rajfajzen najviše ispitana (bar prema javno dostupnim podacima) na raznim slučajevima (npr. oboleli na imunosupresivima i sl).

Ne verujem da će išta da loše da ti bude ni od kineza, al ako si već na nekoj terapiji koja potencijalno može da smanjii dejstvo vakcine, najbolje da onda uzmeš najjaču vakcinu.

A u vezi pitanja, ne treba više zakazivanje, vidiš spisak na https://rs.n1info.com/vesti/na-ovih-25-punktova-u-beogradu-mozete-dobiti-trecu-dozu-vakcine-bez-zakazivanja/ i odeš.

Samo da se pohvalim, posle

 

  +

 

danas  

 

Abomination! 

 

 

Quote

The report led by ISS and the health ministry examined data up to Aug. 29 from more than 29 million people who had received two doses of an mRNA vaccine such as those produced by Pfizer and Moderna. It said that in the general population, effectiveness against infection after seven months remained at 89%, while against hospitalisation and death, this time six months after the second dose, it remained at 96% and 99% respectively.

...

In Italy, people are obliged to wear masks indoors and they had been required outdoors before the summer, and stringent behavioural rules have been in place, which may have influenced the results.

The ISS report said that immunocompromised people saw their protection against infection drop from 28 days after the second dose, with the reduction varying widely according to which diseases cause the weakened immune system. In people with co-morbidities but who are not necessarily immunodepressed, the study reported a reduction in protection from infection which declined from 75% 28 days after the second dose to 52% after about seven months.

Efficacy among people over the age of 80 and nursing home residents also decreased slightly but remained above 80%, the ISS said.

Comparing the period in which the Alpha variant was prevalent with that in which the Delta variant was, efficacy against infection fell from 84.8% to 67.1%, while protection against hospitalisation declined much less, from 91.7% to 88.7%.

https://www.reuters.com/business/healthcare-pharmaceuticals/italy-says-mrna-covid-jab-effectiveness-stable-after-7-months-not-all-2021-10-06/

Edited October 8, 20213 yr by vememah

fajzerovao sam se trecom dozom, nije proslo ni tri sata, ruka me otkida

Cera ubila prvu dozu kineza. Za sada sve ok. 

Inace smo hanuma i ja primili trecu dozu kineza i sve ok. 

[/url]  
 

The report led by ISS and the health ministry examined data up to Aug. 29 from more than 29 million people who had received two doses of an mRNA vaccine such as those produced by Pfizer and Moderna. It said that in the general population, effectiveness against infection after seven months remained at 89%, while against hospitalisation and death, this time six months after the second dose, it remained at 96% and 99% respectively.
...
In Italy, people are obliged to wear masks indoors and they had been required outdoors before the summer, and stringent behavioural rules have been in place, which may have influenced the results.
The ISS report said that immunocompromised people saw their protection against infection drop from 28 days after the second dose, with the reduction varying widely according to which diseases cause the weakened immune system. In people with co-morbidities but who are not necessarily immunodepressed, the study reported a reduction in protection from infection which declined from 75% 28 days after the second dose to 52% after about seven months.
Efficacy among people over the age of 80 and nursing home residents also decreased slightly but remained above 80%, the ISS said.
Comparing the period in which the Alpha variant was prevalent with that in which the Delta variant was, efficacy against infection fell from 84.8% to 67.1%, while protection against hospitalisation declined much less, from 91.7% to 88.7%.

Ne znam, ima tu nešto da smo svi (p)ostali ozbiljno zabrinuti za zdravlje putem zaštite ali ima naznaka da će zima biti (skoro) kao i prošla jesen. Povećaće se brojevi koji su zasad ispod srpskih (danas 3.000 novih slučajeva i 30 mrtvih na 60 miliona) ali ne verujem da će se ponoviti zatvaranje kao prošlu NG. Bioskopi, teatri i koncerti povećavaju na 100% kapaciteta, stadioni 75 a diskoteke tek sad i to na 35% (kruži vic da se može đuskati ali je zabranjeno upoznavanje™ jer maske se mogu skinuti samo kad se igra...). Inače je "kultura maski" dostojanstveno primljena, nisam sreo još nikog da podržava skidanje istih, ismevanje ili slično kao na Balkanu... Govori tiho i nosi masku (sa sobom) i ne sme ti niko ništa, na ulici te niko ne gleda popreko. Green pass je doprineo polemikama, posebno oko obaveze istog za posao u kontaktu sa ljudima ali je povećao i procenat vakcinacija, putovanja su olakšana...

1 hour ago, Kelt said:

fajzerovao sam se trecom dozom, nije proslo ni tri sata, ruka me otkida

Isto.

Za sad ništa, čak ni bol na mestu uboda.

Edited October 8, 20213 yr by mraki

Aktuelni podaci o vakcinaciji:

Quote

Broj doza: 6.655.878 – prva doza 3.061.127, druga doza 2.929.468, treća doza 665.283
Državljani RS – prva doza 2.890.804, druga doza 2.777.077, treća doza 661.361
Strani državljani sa boravkom u RS – prva doza 10.423, druga doza 9.530, treća doza 1176
Strani državljani bez boravka u RS – prva doza 159.900, druga doza 142.861, treća doza 2.746
ažurirano 07.10.2021

https://vakcinacija.gov.rs/

 

Podaci od pre nedelju dana:

Quote

Broj doza: 6.497.670 – prva doza 3.040.293, druga doza 2.901.882, treća doza 555.495
Državljani RS – prva doza 2.870.854, druga doza 2.750.459, treća doza 552.760
Strani državljani sa boravkom u RS – prva doza 10.281, druga doza 9.399, treća doza 852
Strani državljani bez boravka u RS – prva doza 159.158, druga doza 142.024, treća doza 1.883
ažurirano 30.09.2021

 

Za 7 dana srpskim državljanima dato:

prvih 19.950
drugih 26.618
trećih doza 108.601
155.169 doza ukupno.

 

Dakle, dnevni prosek ove nedelje je 7x manji od toga:
prvih 2850 (-20%)
drugih 3803 (+11%)
trećih 15.514 (+47%)
sveukupno 22.167 (+26%)

 

Ukupan dnevni prosek datih doza porastao je za preko 4500 u odnosu na prošlu nedelju, znatno su porasle treće doze, neznatno druge, a prve su se osetno smanjile (dakle, nema nikakvog povećanja vakcinacije nevakcinisanih, naprotiv).

 

Dnevni prosek prošle nedelje:

prvih 3555
drugih 3433
trećih 10.588
sveukupno 17.576

 

Broj potpuno vakcinisanih osoba pre 6 meseci, 7.4. bio je 1.134.776. To znači da je trećom dozom dosad vakcinisano svega 58% onih koji bi mogli da je prime jer imaju navršenih pola godine od druge doze.

Edited October 8, 20213 yr by vememah

Primio trecu dozu jutros na sajmu, fajzer posle dva kineza. Nema guzve, sve gotovo za 15 min

U mom okruzenju se raja razletela po trecu dozu 

Sad išao sa bratom u SM da primi drugu dozu... prva je bila Astra ali je sad nema. Pokušao da primi Fajzera kao drugu dozu jer sva istraživanja pokazuju da je to dobar kombo... ne može naravno. Mora da prođe 6 meseci i onda može da primi prvu dozu Fajzera Jedno 30 ljudi za pola sata došlo, verovatno jer je vikend a punkt u Hali radi od 8-16 radnim danima pa ne stižu ljudi...

Sent from my M2002J9G using Tapatalk

Imam bol u ramenu, i generalno blagi bol u kostima, temperature za sad nema, samo taj neki osećaj kao da gorim na momente. Ali uspeo sam juče da pokisnem i smrznem se, pa je možda i do toga. 
Ionako sam isplanirao vakcinu u petak, pa bolovanje i ležanje preko vikenda, šteta bi bila sad da se ne iskoristi. 
 

Kako si @Kelt, ti imaš najburnije reakcije?

Edited October 9, 20213 yr by mraki

WHO Director-General, Dr Tedros Adhanom Ghebreyesus, 7.10.2021:

Quote

At this press conference almost exactly one year ago I said that the world was eagerly anticipating the results of trials of vaccines against COVID-19. I also said that once we had a vaccine we must use it effectively by making sure it's available to all countries equitably.

The development and approval of vaccines in record time took us to the summit of scientific achievement. Now we stand on the precipice of failure if we don't make the benefits of science available to all people in all countries right now.

More than 6.4 billion vaccine doses have now been administered globally and almost one-third of the world's population is fully vaccinated against COVID-19 but those numbers mask a horrifying inequity.

High and upper-middle-income countries have used 75% of all vaccines produced so far. Low-income countries have received less than 0.5% of the world's vaccines. In Africa less than 5% of people are fully vaccinated.

As you know, earlier this year WHO set a target for all countries to vaccinate 10% of their populations by the end of September. 56 countries didn't make it through no fault of their own.

Today WHO is launching the strategy to achieve global COVID-19 vaccination by mid 2022. The strategy outlines the road we must all take together to achieve our targets of vaccinating 40% of the population of every country by the end of this year and 70% by the middle of next year.

Achieving these targets will require at least 11 billion vaccine doses. This is not a supply problem. It is an allocation problem. By the end of September almost 6.5 billion doses had already been administered worldwide.

With global vaccine production now at nearly 1.5 billion doses per month there is enough supply to achieve our targets provided they're distributed equitably.

Contracts are in place for the remaining five billion doses but it's critical that those doses go where they are needed most with priority given to older people, health workers and other at-risk groups.We can only achieve our targets if the countries and companies that control vaccine supply put contracts for COVAX and the African Vaccine Acquisition Trust, AVAT, first for deliveries and donated doses.

We have the tools to bring the pandemic under control if we use them properly and share them fairly and we must remember that vaccines are a powerful tool but not the only one. All countries must continue with a comprehensive risk-based approach of public health and social measures in combination with equitable vaccination.

Vaccine equity will accelerate the end of the pandemic. Achieving WHO's vaccine equity targets will substantially increase population immunity globally, protect health systems, enable economies to fully restart and reduce the risk of new variants emerging.

https://www.who.int/publications/m/item/covid-19-virtual-press-conference-transcript---7-october-2021

Edited October 9, 20213 yr by vememah